Gilenya shows promise in pediatric MS on: September 06, 2017, 08:19:57 pm #1 From MedPage Today, September 5, 2017:"MS Drug Works in Kids" Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
Re: Gilenya shows promise in pediatric MS Reply #1 on: May 14, 2018, 08:47:09 pm #2 More on this in the MSAA Newsletter, May 14, 2018: FDA Approves Gilenya® for Pediatric MS | MSAA Gilenya® (fingolimod) was approved by the United States Food and Drug Administration (FDA) for the treatment of children and adolescents, ages 10 through 17, with relapsing multiple sclerosis (MS). MSAA · mymsaa.org Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
